Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

 
 

Harpoon Therapeutics, Inc. (HARP) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $8.02 Metrics
OS: 38.8 M -1345 % ROE
Market cap: $311 M -554 % ROIC
Net cash: $32.8 M $0.85 per share
EV: $278 M

 
TTM Valuation
EBITDA ($34.9) M
EBIT ($37.1) M
EPS ($1.19)

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-22Dec-31-21Dec-05-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16
Revenues31.923.723.717.45.84.80.70.0
            Revenue growth34.9%35.6% 202.0%21.6%570.9%  
Cost of goods sold0.00.00.00.00.00.00.00.0
Gross profit31.923.723.717.45.84.80.70.0
            Gross margin100.0%100.0%100.0%100.0%100.0%100.0%100.0% 
Selling, general and administrative100.2140.4 68.864.032.517.211.1
General and administrative  18.3     
EBIT-68.3-116.8-66.8-51.3-58.2-27.7-16.50.0
            EBIT margin-214.1%-493.6%-282.4%-294.3%-1007.5%-583.7%-2334.5% 
Pre-tax income-67.7-116.7-116.7-49.9-55.6-27.4-16.8-11.4
Income taxes0.00.00.00.00.00.00.00.0
            Tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income-67.7-116.7-116.7-49.9-55.6-27.4-16.8-11.4
            Net margin-212.2%-493.5%-493.5%-286.1%-962.0%-576.1%-2377.1% 
 
Diluted EPS($2.04)($3.62)($3.62)($1.99)($2.56)($25.65)($18.81)($21.61)
Shares outstanding (diluted)33.232.332.325.021.71.10.90.5
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy